909 results on '"Jardine, Alan"'
Search Results
2. Contributors
3. Special Populations
4. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis
5. Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients
6. Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Naïve Patients
7. Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial
8. #2063 Safety and efficacy of vadadustat vs darbepoetin alfa in patients on maintenance dialysis by prespecified subgroups of baseline ESA dose
9. Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial
10. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
11. An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial
12. The ViKTORIES trial: A randomized, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients
13. Atherosclerotic Vascular Disease Associated with Chronic Kidney Disease
14. A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients
15. A comparative study of 5 different antibiotic prophylaxis regimes in 4500 total knee replacements
16. Professor Gordon T. McInnes
17. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review
18. The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population
19. Genetic markers associated with long-term cardiovascular outcome in kidney transplant recipients
20. Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort
21. Contributors
22. Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association study
23. 38 - Special Populations: Chronic Kidney Disease
24. 37 - Special Patient Populations: Transplant Recipients
25. Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Non-Dialysis Chronic Kidney Disease Patients: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients
26. Safety Endpoints With Vaadustat Versus Darbepoetin Alfa in Nondialysis CKD Patients: A Post hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Naïve Patients
27. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
28. Cardiovascular Disease in Renal Transplantation
29. Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR Trial
30. Dyslipidemia in the Kidney Transplant Patient
31. Cardiovascular complications of chronic kidney disease
32. Studies on Atrial Natriuretic Peptide
33. Research cardiac magnetic resonance imaging in end stage renal disease - incidence, significance and implications of unexpected incidental findings
34. An analysis of vascular access thrombosis events from the Proactive IV Iron Therapy in Hemodialysis Patients (PIVOTAL) trial
35. An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial
36. An Open‐Label Dose‐Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients
37. Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway
38. High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study
39. A national appraisal of haemodialysis vascular access provision in Scotland
40. Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation
41. High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime
42. Calculated cardiovascular risk after conversion from calcineurin inhibitor to belatacept in kidney transplant recipients: A randomized controlled trial
43. Cardiovascular disease
44. Lipid disorders of patients with chronic kidney disease
45. Impact of Genetic Polymorphisms in Cytomegalovirus Glycoprotein B on Outcomes in Solid-Organ Transplant Recipients with Cytomegalovirus Disease
46. Cardiovascular complications of chronic renal disease
47. Prevention of cardiovascular disease in adult recipients of kidney transplants
48. Ga Dolinium Contrast May Be Risky in Kidney Disease
49. ‘To block or not to block’; whether to continue renin–angiotensin–aldosterone system blockade in advanced chronic kidney disease
50. Special Patient Populations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.